Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer

Published:2000-12 Issue:3 Volume:30 Page:199-202
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Chen Yuh-Min,Perng Reury-Perng,Whang-Peng Jacqueline,Wu Hsiao-Wei,Lin Wei-Chun,Tsai Chun-Ming

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference19 articles.

1. Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?;Grilli;J. Clin. Oncol.,1993

2. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions;Bunn;Clin. Cancer Res.,1998

3. Triplet chemotherapy with gemcitabine, a platinum, and a third agent in the treatment of advanced non-small cell lung cancer;Bunn;Semin. Oncol.,1999

4. Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study;Abratt;J. Clin. Oncol.,1994

5. Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study;Perng;J. Clin. Oncol.,1997

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tamoxifen: The Past, Present, and Future of a Previous Orphan Drug;European Journal of Medical and Health Sciences;2022-05-24

2. Gemcitabine, Ifosfamide, and Cisplatin Combination (GIP) in Treatment of Patients With Locally Advanced or Metastatic Nonsmall Cell Lung Cancer;American Journal of Clinical Oncology;2006-08

3. Ifosfamide in Non-Small Cell Lung Cancer;Oncology;2003

4. Prolonged Infusion of Gemcitabine: Clinical and Pharmacodynamic Studies During a Phase I Trial in Relapsed Acute Myelogenous Leukemia;Journal of Clinical Oncology;2002-02-01